Advanced search
Publication Cover
Postgraduate Medicine Volume 123, 2011 - Issue 1
Submit an article Journal homepage
29
Views
0
CrossRef citations to date
0
Altmetric
Practice Pearl

Prevention of NSAID-Associated Gastric Ulcers: Comparison of PN 400 (Enteric-Coated Naproxen with Esomeprazole) versus Enteric-Coated Naproxen Alone

Derek M. Tang Temple University School of Medicine, Department of Medicine, Philadelphia, PACorrespondence[email protected]
, MD &
Lawrence Ward Temple University School of Medicine, Department of Medicine, Philadelphia, PA
, MD, MPH, FACP
Pages 169-171 | Published online: 13 Mar 2015

References

  • . Bhatt DL, Scheiman J, Abraham NS, ; American College of Cardiology Foundation; American College of Gastroenterology; American Heart Association. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. Am J Gastroenterol. 2008;103(11):2890–2907
  • . Scheiman JM, Yeomans ND, Talley NJ, . Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors. Am J Gastroenterol. 2006;101(4):701–710
  • . Talley NJ, Evans JM, Fleming KC, Harmsen WS, Zinsmeister AR, Melton LJ 3rd. Nonsteroidal antiinflammatory drugs and dyspepsia in the elderly. Dig Dis Sci. 1995;40(6):1345–1350
  • . Abraham NS, El-Serag HB, Johnson ML, . National adherence to evidence-based guidelines for the prescription of nonsteroidal anti-inflammatory drugs. Gastroenterology. 2005;129(4):1171–1178
  • . ; American College of Rheumatology Ad Hoc Group on Use of Selective and Nonselective Nonsteroidal Antiinflammatory DrugsDesai SP, Solomon DH, Abramson SP, . Recommendations for use of selective and non-selective nonsteroidal antiinflammatory drugs: an American College of Rheumatology white paper. Arthritis Rheum. 2008;59(8):1058–1073
  • . Chen YF, Jobanputra P, Barton P, . Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation. Health Technol Assess. 2008;12(11):1–278, iii
  • . Mahe I, Leizorovicz A, Caulin C, Bergmann JF. Aspirin for the prevention of cardiovascular events in the elderly. Drugs Aging. 2003;20(13):999–1010
  • . Graham DY, Chan FK. NSAIDs, risks, and gastroprotective strategies: current status and future. Gastroenterology. 2008;134(4):1240–1246
  • . Bjorkman DJ. Current status of nonsteroidal anti-inflammatory drug (NSAID) use in the United States: risk factors and frequency of complications. Am J Med. 1999;107(6 A):3S–10S
  • . Targownik LE, Metge CJ, Leung S, Chateau DG. The relative efficacies of gastroprotective strategies in chronic users of nonsteroidal anti-inflammatory drugs. Gastroenterology. 2008;134(4):937–944
  • . van Soest EM, Sturkenboom MC, Dieleman JP, Verhamme KM, Siersema PD, Kuipers EJ. Adherence to gastroprotection and the risk of NSAID-related upper gastrointestinal ulcers and haemorrhage. Aliment Pharmacol Ther. 2007;26(2):265–275
  • . Goldstein JL, Hochberg MC, Fort JG, Zhang Y, Hwang C, Sostek M. Clinical trial: the incidence of NSAID-associated endoscopic gastric ulcers in patients treated with PN 400 (naproxen plus esomeprazole magnesium) vs. enteric-coated naproxen alone. Aliment Pharmacol Ther. 2010;32(3):401–413
  • . Sturkenboom MC, Burke TA, Tangelder MJ, Dieleman JP, Walton S, Goldstein JL. Adherence to proton pump inhibitors or H2-receptor antagonists during the use of non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther. 2003;18(11–12):1137–1147
  • . Laine L, Connors L, Griffin MR, Curtis SP, Kaur A, Cannon CP. Prescription rates of protective co-therapy for NSAID users at high GI risk and results of attempts to improve adherence to guidelines. Aliment Pharmacol Ther. 2009;30(7):767–774
  • . Birk JW, Myers M. A fixed dose combination of ibuprofen and famotidine. Expert Opin Investig Drugs. 2009;18(9):1385–1391
  • . DeVault KR, Talley NJ. Insights into the future of gastric acid suppression. Nat Rev Gastroenterol Hepatol. 2009;6(9):524–532
  • . Bhatt DL, Cryer BL, Contant CF, ; COGENT Investigators. Clopidogrel with or without Omeprazole in Coronary Artery Disease. N Engl J Med. 2010;363(20):1909–1917
  • . Southworth MR, Temple R. Interaction of clopidogrel and omeprazole. N Engl J Med. 2010;363(20):1977

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.